GGrantIndex
← Leaderboards

Amir A. Zeki

University Of California At Davis

$3,328,723
Attributed
$3,328,723
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $642.6K · FY201425
$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,328,723 · 5

By mechanism

R01$2,348,228 · 1
K08$434,878 · 1
R03$314,000 · 2
R21$231,617 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California At Davis

Same institution · by research overlap

Others in their field

Top investigators on “Asthma

Research focus

AsthmaAirway HyperresponsivenessStructure Of Parenchyma Of LungLungAsthmaticPathway InteractionsAirway InflammationMouse ModelProductionMevalonateInterleukin-13Pharmaceutical PreparationsOxidoreductaseCellsCoenzyme AMediatingBronchoalveolar LavageInhalationAirway RemodelingPhosphorylationCytokineInflammationAgonistMass Spectrum Analysis

Grant awards (13)

Inhaled Pitavastatin for the Treatment of Asthma: A New Therapeutic Paradigm$231,617
R21 · FY2025 · AI · contact PI
Reducing Airway Smooth Muscle Tone Using Inhaled Statins$436,292
R01 · FY2024 · HL · contact PI
Reducing Airway Smooth Muscle Tone Using Inhaled Statins$469,917
R01 · FY2023 · HL · contact PI
Reducing Airway Smooth Muscle Tone Using Inhaled Statins$474,028
R01 · FY2022 · HL · contact PI
Reducing Airway Smooth Muscle Tone Using Inhaled Statins$482,359
R01 · FY2021 · HL · contact PI
Reducing Airway Smooth Muscle Tone Using Inhaled Statins$485,632
R01 · FY2020 · HL · contact PI
Statin Lipophilicity as a Determinant of Drug Airway Distribution: A Pilot Study to Identify the Most Potent Statin(s) for the Treatment of Severe Asthma.$78,500
R03 · FY2020 · AI · contact PI
Isoprenoid Biology in Asthma: Proof-of-Principle and Method Development$78,500
R03 · FY2020 · HL · contact PI
Isoprenoid Biology in Asthma: Proof-of-Principle and Method Development$78,500
R03 · FY2019 · HL · contact PI
Statin Lipophilicity as a Determinant of Drug Airway Distribution: A Pilot Study to Identify the Most Potent Statin(s) for the Treatment of Severe Asthma.$78,500
R03 · FY2019 · AI · contact PI
The Modulation of Eotaxin Expression by Statins: Implications for Asthma Therapy$170,320
K08 · FY2016 · HL · contact PI
The Modulation of Eotaxin Expression by Statins: Implications for Asthma Therapy$132,279
K08 · FY2015 · HL · contact PI
The Modulation of Eotaxin Expression by Statins: Implications for Asthma Therapy$132,279
K08 · FY2014 · HL · contact PI